{
    "organizations": [],
    "uuid": "814d9f1475d4f53037a9f3b9266d0c3c1ff10863",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL8N1PB20N",
    "ord_in_thread": 0,
    "title": "BRIEF-MolMed: Zalmoxis Can Be Reimbursed In Germany For EUR 163,900 Per Infusion",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - MOLECULAR MEDICINE SPA:\n* SAYS THAT AS OF JAN 15 ZALMOXIS CAN BE PRESCRIBED AND REIMBURSED IN GERMANY AT THE PRICE OF EUR 163,900 PER INFUSION\n* APPROVED DOSAGE FORESEES ONE OR MORE INFUSIONS, UP TO A MAXIMUM OF FOUR, TILL IMMUNE-RECONSTITUTION IS ACHIEVED\n* MOLMED WILL BE RESPONSIBLE FOR THE PRODUCTION AND SUPPLY OF ZALMOXIS, WHILE DOMPÉ FARMACEUTICI WILL CONDUCT ACTIVITIES AIMED AT MARKETING THE THERAPY IN GERMANY\n* DOMPÉ WILL PAY MOLMED A PURCHASE PRICE PROPORTIONAL TO THE REIMBURSED PRICE OF THE PRODUCT\nSource text for Eikon:\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-16T17:25:00.000+02:00",
    "crawled": "2018-01-17T19:47:07.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "molecular",
        "medicine",
        "spa",
        "say",
        "jan",
        "zalmoxis",
        "prescribed",
        "reimbursed",
        "germany",
        "price",
        "eur",
        "per",
        "infusion",
        "approved",
        "dosage",
        "foresees",
        "one",
        "infusion",
        "maximum",
        "four",
        "till",
        "achieved",
        "molmed",
        "responsible",
        "production",
        "supply",
        "zalmoxis",
        "dompé",
        "farmaceutici",
        "conduct",
        "activity",
        "aimed",
        "marketing",
        "therapy",
        "germany",
        "dompé",
        "pay",
        "molmed",
        "purchase",
        "price",
        "proportional",
        "reimbursed",
        "price",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}